Press Releases

IGC to Re-list Securities on Alternative Exchange

BETHESDA, MD. October 29, 2018 / India Globalization Capital, Inc. (NYSE American: IGC) announces today that it is in the process of evaluating applications with alternative exchanges in the U.S. and Canada to list its common stock for public trading. IGC is working diligently to complete this process as quickly as possible and will provide…

IGC to Enter the Hemp/CBD-Infused Energy Drink Space

BETHESDA, MD. September 25, 2018 / India Globalization Capital, Inc. (NYSE AMERICAN: IGC) announces today that it has executed a distribution and partnership agreement for several products including a sugar free, energy drink called ‘Nitro G’. IGC will pay 797,000 shares of restricted, unregistered, common stock, for a 10-year agreement, with an option for multiple…

Entry Into a Material Definitive Agreement

ATM Agency Agreement On September 22, 2018, India Globalization Capital, Inc. (the “Company”) entered into an At-the-Market Offering Agreement (the “Agreement”) with The Benchmark Company, LLC (“Benchmark”) and ViewTrade Securities, Inc. (“ViewTrade” and together with Benchmark, the “Managers”) pursuant to which the Managers will act as the Company’s sales agents with respect to the issuance…

IGC Announces Results of its 2018 Annual Stockholders Meeting

India Globalization Capital, Inc. (NYSE American: IGC) announces that during its Annual Meeting of Shareholders scheduled for, and convened on August 6, 2018, voting on all matters as disclosed on the Definitive Proxy on Form 14A filed with the SEC on July 6, 2018 were passed. Only stockholders of record on the record date of…

IGC Announces Financial Results for Quarter Ended June 30, 2018

BETHESDA, MD. August 2, 2018 – India Globalization Capital, Inc. (NYSE AMERICAN: IGC) today announces financial results for the quarter ended June 30, 2018, which is the first quarter of its 2019 fiscal year. Total revenue was approximately $1.48 million for the three months ended June 30, 2018, as compared to approximately $53 thousand for…

IGC Announces Financial Results for Fiscal Year Ended March 31, 2018

BETHESDA, Md., June 21, 2018 (GLOBE NEWSWIRE) — India Globalization Capital, Inc. (NYSE American:IGC) announces financial results for the fiscal year ended March 31, 2018. “In fiscal 2018, the Company’s focus was to develop, manufacture, and lay the foundation to commercialize our lead product Hyalolex, an alternative oral cannabinoid-based therapy for the treatment of symptoms…

India Globalization Capital Files Patent for Hyalolex Formulation

Bethesda, MD. April 10, 2018 India Globalization Capital, Inc. (NYSE Amex: IGC) today announced that it has filed a method and composition patent with the U.S.P.T.O. for the formulation of Hyalolex (IGC-507), which helps address some symptoms of Alzheimer’s disease including the buildup of plaques and tangles, anxiety, aggression and sleep disorders among others. This…

IGC Announces Third Quarter Financial Results

Bethesda, February 20, 2018 (ACCESSWIRE) – India Globalization Capital, Inc. (NYSE MKT: IGC) announced financial results for the third quarter ended December 31, 2017 for the fiscal year that ends March 31, 2018 (the “FYE2018 Q3”) Financials Analysis Revenue for fiscal Q3 2018 was $762,000 compared to $250,000 for fiscal Q3 2017. The increase in revenue is attributable…

India Globalization Capital’s CEO to Speak at CEO Healthcare Symposium in NY on February 12 & 13

Ram Mukunda will be a speaker at the upcoming CEO Healthcare Symposium in New York on February 12 and February 13, 2018.  His presentation will include commentary on the Company’s efforts in developing and commercializing cannabis–based pharmaceuticals including Hyalolex for Alzheimer’s disease. 2018 Key Objectives “We are preparing the groundwork necessary to prepare Hyalolex, our…

Stop Israel from Exporting MMJ to the USA. This is a good development for IGC and others in the US

Recent News that Trump to Stop Israel from exporting MMJ to the USA. This is a good development for the IGC and others in the US, as there will be less competition. According to Yahoo news, “Trump Stops Israel From Exporting Medical Marijuana, Putting Future of $1 Billion Industry in Doubt” Its a great opportunity for India Globalization Capital…

Ram Mukunda, CEO Podcast with Stockhouse

Cannabis is an exciting, emerging sector, with enormous growth and investment potential for decades to come.The blockchain is a red-hot tech trend. Its proponents insist that this is a revolutionary technology, with virtually limitless potential for future applications. IGC is a cannabis biopharma corporation. While the Company continues some legacy operations relating to commodity trading,…

Ram Mukunda, CEO of India Globalization Capital, Inc., Joins Everett Jolly on Uptick Newswire’s “Stock Day” Podcast

India Globalization Capital, Inc. (NYSE American:IGC) (the “Company”) provides IGC operations update on Stock Day Podcast with Everett Jolly. Ram Mukunda, CEO of India Globalization Capital, Inc., Joins Everett Jolly IGC has a legacy business in infrastructure focused primarily in India, Malaysia and Hong Kong.  More recently the company has expanded into the Cannabis Pharmacy…

SeeThruEquity Issues Update on India Globalization Capital, Inc. (IGC) and Updates Price Target to $2.00

SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has issued an update on India Globalization Capital, Inc. (NYSE American: IGC) and updated its price target to $2.00

India Globalization Capital Reports Promising Spatial Memory Results in Alzheimer’s Study

Bethesda, MD. January 2, 2017– India Globalization Capital, Inc. (NYSE-MKT: IGC) provides compelling in vivo data compiled from genetically engineered mice to mimic Alzheimer’s shows marked improvement in spatial memory. Scope of Studies Transgenic mice with a gene introduced to mimic Alzheimer’s were used to gauge the impact of IGC-AD1 on learning and memory function. A common model…

India Globalization Capital to use Blockchain to Address Issues Specific to the Medical Cannabis Industry

India Globalization Capital, Inc. (NYSE American: IGC), today announces that it will leverage its existing team of technology and healthcare experts to develop methods utilizing blockchain in areas such as product identification assurance (PIA). According to a recent study that was published in JAMA and detailed on www.pennmedicine.org, nearly 70% of all cannabidiol products sold online are either…

Update on Hyalolex for Alzheimer’s Commercialization Strategy

IGC Readies Line of Medical Dispensary Products Targeting Alzheimer’s Disease Based on Novel Data

Alzheimer’s Disease: Cannabis Formulation Shows Promise

Scientific IGC’s CEO and Key Advisor Quoted in “HIGH TIMES” Article on THC and Alzheimer’s Disease

IGC Builds Team Adding Industry Leader